Institut Català de la Salut
[Askarian M] Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Health Behavior Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. [Semenov A] Ekaterinburg Research Institute of Viral Infections SRC VB Vector, Ekaterinburg, Russia. [Llopis F] Emergency Department, Bellvitge University Hospital, l’Hospitalet de Llobregat, Spain. [Rubulotta F] Department of Intensive Care Medicine, Charing Cross Hospital, Imperial College, NHS Trust, London, UK. [Dragovac G] Department of Epidemiology, Faculty of Medicine, University of Novi Sad, Serbia. Center of Disease Prevention and Control, Institute of Public Health of Vojvodina, Novi Sad, Serbia. [Pshenichnaya N] Clinical Department of Infectious Pathology, Central Research Institute of Epidemiology, Moscow, Russia. [Rello J] Grup de Recerca Clínica/Innovació en la Pneumònia i Sèpsia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CHRU Nimes, Nimes, France
Vall d'Hebron Barcelona Hospital Campus
2022-07-20T11:48:33Z
2022-07-20T11:48:33Z
2022-01-06
COVID-19 vaccines; Health personnel; Vaccination coverage
Vacunas COVID-19; Personal sanitario; Cobertura vacunal
Vacunes COVID-19; Personal sanitari; Cobertura de vacunació
The aim of this study was to investigate the COVID-19 vaccination acceptance rate and its determinants among healthcare workers in a multicenter study. This was a cross-sectional multi-center survey conducted from February 5 to April 29, 2021. The questionnaire consisted of 26 items in 6 subscales. The English version of the questionnaire was translated into seven languages and distributed through Google Forms using snowball sampling; a colleague in each country was responsible for the forward and backward translation, and also the distribution of the questionnaire. A forward stepwise logistic regression was utilized to explore the variables and questionnaire factors tied to the intention to COVID-19 vaccination. 4630 participants from 91 countries completed the questionnaire. According to the United Nations Development Program 2020, 43.6 % of participants were from low Human Development Index (HDI) regions, 48.3 % high and very high, and 8.1 % from medium. The overall vaccination hesitancy rate was 37 %. Three out of six factors of the questionnaire were significantly related to intention to the vaccination. While ‘Perceived benefits of the COVID-19 vaccination’ (OR: 3.82, p-value<0.001) and ‘Prosocial norms’ (OR: 5.18, p-value<0.001) were associated with vaccination acceptance, ‘The vaccine safety/cost concerns’ with OR: 3.52, p-value<0.001 was tied to vaccination hesitancy. Medical doctors and pharmacists were more willing to take the vaccine in comparison to others. Importantly, HDI with OR: 12.28, 95 % CI: 6.10-24.72 was a strong positive determinant of COVID-19 vaccination acceptance. This study highlighted the vaccination hesitancy rate of 37 % in our sample among HCWs. Increasing awareness regarding vaccination benefits, confronting the misinformation, and strengthening the prosocial norms would be the primary domains for maximizing the vaccination coverage. The study also showed that the HDI is strongly associated with the vaccination acceptance/hesitancy, in a way that those living in low HDI contexts are more hesitant to receive the vaccine.
Artículo
Versión publicada
Inglés
COVID-19 (Malaltia) - Vacunació; Personal mèdic; DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus
EXCLI Journal Managing Office
EXCLI Journal;21
https://doi.org/10.17179/excli2021-4439
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]